OBJECTIVES: To report on the short-term morbidity of radical nephrectomy in 32 @entity1 with poorer performance status and more advanced primary @entity1358 ( @entity1358 ). Nephrectomy followed by immunotherapy has been shown to improve survival in selected, good performance status @entity1 with metastatic @entity1358 . METHODS: We report on 32 @entity1 who underwent radical nephrectomy (20 open procedures and 12 laparoscopic) in the setting of metastatic @entity1358 at Indiana University between 1999 and 2002. The study group included @entity1 with advanced @entity5 (inferior vena cava involvement, large size, and involvement of adjacent structures). The @entity1 ' performance status score ranged from 0 to 2. RESULTS: The average hospital stay was 5.1 days. No significant @entity3816 were encountered, and @entity260 occurred in 6 @entity1 , including one perioperative @entity204 . At 4 weeks postoperatively, 21 (72.4%) of 29 assessable @entity1 had a performance status equal to, or better than, their preoperative status, including 4 @entity1 who converted from a preoperative performance status of 2 to 0 or 1 postoperatively. Eleven @entity1 (34.4%) went on to receive postoperative immunotherapy. CONCLUSIONS: The results of our study demonstrated that radical nephrectomy in the setting of metastatic @entity1358 has a low morbidity and acceptable recovery in these @entity1 with advanced @entity5 and poorer performance status.

Nephrectomy for metastatic XXXX : Indiana University experience.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity5 :: ('MESH:D009369', 'Disease') :: ['primary tumors'] @entity260 :: ('MESH:D011183', 'Disease') :: ['postoperative complications'] @entity1358 :: ('MESH:D002292', 'Disease') :: ['renal cell carcinoma', 'RCC'] @entity204 :: ('MESH:D003643', 'Disease') :: ['death'] @entity3816 :: ('MESH:D007431', 'Disease') :: ['intraoperative complications']
@entity1358 :: (MESH:D002292,Disease) :: ['renal cell carcinoma']
